State Street Corp A Tyr Pharma Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in A Tyr Pharma Inc stock. As of the latest transaction made, State Street Corp holds 166,808 shares of LIFE stock, worth $260,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,808
Previous 166,808
-0.0%
Holding current value
$260,220
Previous $235,000
38.3%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LIFE
# of Institutions
59Shares Held
33.5MCall Options Held
7.5KPut Options Held
3.2K-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$15.9 Million0.05% of portfolio
-
Logos Global Management LP San Francisco, CA3.1MShares$4.84 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$4.14 Million0.0% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$3.84 Million1.51% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$2.97 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $44.7M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...